Risk of thrombosis and major bleeding in JAK2-positive myeloproliferative neoplasm patients receiving low-dose aspirin: a systematic review and meta-analysis
| dc.contributor.author | Kimpton, Miriam | |
| dc.contributor.author | Delluc, Aurelien | |
| dc.contributor.author | Fergusson, Dean | |
| dc.contributor.author | Carrier, Marc | |
| dc.date.accessioned | 2020-02-24T22:45:56Z | |
| dc.date.available | 2020-02-24T22:45:56Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Protocol for a systematic review and meta-analysis | en_US |
| dc.identifier.uri | http://hdl.handle.net/10393/40206 | |
| dc.identifier.uri | https://doi.org/10.20381/ruor-24439 | |
| dc.language.iso | en | en_US |
| dc.subject | Myeloproliferative Neoplasms | en_US |
| dc.subject | Aspirin | en_US |
| dc.title | Risk of thrombosis and major bleeding in JAK2-positive myeloproliferative neoplasm patients receiving low-dose aspirin: a systematic review and meta-analysis | en_US |
| dc.type | Other | en_US |
